Pedro M. Valencia

4.6k total citations · 2 hit papers
17 papers, 3.7k citations indexed

About

Pedro M. Valencia is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Pedro M. Valencia has authored 17 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Biomedical Engineering, 8 papers in Biomaterials and 5 papers in Molecular Biology. Recurrent topics in Pedro M. Valencia's work include Nanoparticle-Based Drug Delivery (8 papers), Innovative Microfluidic and Catalytic Techniques Innovation (6 papers) and Microfluidic and Bio-sensing Technologies (4 papers). Pedro M. Valencia is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), Innovative Microfluidic and Catalytic Techniques Innovation (6 papers) and Microfluidic and Bio-sensing Technologies (4 papers). Pedro M. Valencia collaborates with scholars based in United States, South Korea and Bulgaria. Pedro M. Valencia's co-authors include Omid C. Farokhzad, Róbert Langer, Rohit Karnik, Nazila Kamaly, Zeyu Xiao, Aleksandar F. Radovic‐Moreno, Minsoung Rhee, Liangfang Zhang, Stephen J. Lippard and Nagesh Kolishetti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Chemical Society Reviews and Advanced Materials.

In The Last Decade

Pedro M. Valencia

17 papers receiving 3.7k citations

Hit Papers

Targeted polymeric therapeutic nanoparticles: design, dev... 2012 2026 2016 2021 2012 2012 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pedro M. Valencia United States 13 2.0k 1.8k 1.2k 495 438 17 3.7k
Peisheng Xu United States 32 1.2k 0.6× 1.3k 0.7× 1.3k 1.0× 440 0.9× 298 0.7× 63 3.3k
James D. Byrne United States 19 1.2k 0.6× 1.4k 0.8× 951 0.8× 423 0.9× 242 0.6× 45 2.9k
Irène Brigger France 10 1.5k 0.7× 2.1k 1.2× 1.0k 0.9× 827 1.7× 549 1.3× 11 3.7k
Stephanie E. A. Gratton United States 9 1.4k 0.7× 1.6k 0.9× 1.0k 0.8× 891 1.8× 299 0.7× 13 3.3k
Kyung Hyun Min South Korea 29 2.0k 1.0× 2.4k 1.3× 1.3k 1.1× 683 1.4× 498 1.1× 71 4.2k
Robby A. Petros United States 12 1.5k 0.7× 1.9k 1.1× 1.5k 1.2× 664 1.3× 261 0.6× 21 3.9k
Vimalkumar Balasubramanian Finland 25 1.4k 0.7× 1.6k 0.9× 1.2k 1.0× 646 1.3× 217 0.5× 48 3.2k
Allan E. David United States 32 1.7k 0.9× 1.9k 1.1× 1.2k 1.0× 677 1.4× 207 0.5× 64 3.8k
Etgar Levy‐Nissenbaum Israel 18 1.2k 0.6× 1.4k 0.8× 2.3k 1.9× 601 1.2× 581 1.3× 27 4.3k
Benjamin A. Teply United States 20 1.4k 0.7× 1.9k 1.1× 1.8k 1.5× 399 0.8× 413 0.9× 53 4.1k

Countries citing papers authored by Pedro M. Valencia

Since Specialization
Citations

This map shows the geographic impact of Pedro M. Valencia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro M. Valencia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro M. Valencia more than expected).

Fields of papers citing papers by Pedro M. Valencia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro M. Valencia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro M. Valencia. The network helps show where Pedro M. Valencia may publish in the future.

Co-authorship network of co-authors of Pedro M. Valencia

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro M. Valencia. A scholar is included among the top collaborators of Pedro M. Valencia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro M. Valencia. Pedro M. Valencia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Valencia, Pedro M., et al.. (2017). The human microbiome: opportunity or hype?. Nature Reviews Drug Discovery. 16(12). 823–824. 13 indexed citations
2.
Valencia, Pedro M., et al.. (2017). The immuno-oncology race: myths and emerging realities. Nature Reviews Drug Discovery. 16(2). 83–84. 13 indexed citations
3.
Farokhzad, Omid C., Jong‐Min Lim, Nicolas Bertrand, et al.. (2013). Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
4.
Lim, Jong‐Min, Nicolas Bertrand, Pedro M. Valencia, et al.. (2013). Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study. Nanomedicine Nanotechnology Biology and Medicine. 10(2). 401–409. 133 indexed citations
5.
Valencia, Pedro M., Eric M. Pridgen, Minsoung Rhee, et al.. (2013). Microfluidic Platform for Combinatorial Synthesis and Optimization of Targeted Nanoparticles for Cancer Therapy. ACS Nano. 7(12). 10671–10680. 191 indexed citations
6.
Salvador-Morales, Carolina, Pedro M. Valencia, Weiwei Gao, Rohit Karnik, & Omid C. Farokhzad. (2012). Spontaneous Formation of Heterogeneous Patches on Polymer–Lipid Core–Shell Particle Surfaces during Self‐Assembly. Small. 9(4). 511–517. 17 indexed citations
7.
Kamaly, Nazila, Zeyu Xiao, Pedro M. Valencia, Aleksandar F. Radovic‐Moreno, & Omid C. Farokhzad. (2012). Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chemical Society Reviews. 41(7). 2971–2971. 1355 indexed citations breakdown →
8.
Kamaly, Nazila, Zeyu Xiao, Pedro M. Valencia, Aleksandar F. Radovic‐Moreno, & Omid C. Farokhzad. (2012). ChemInform Abstract: Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation. ChemInform. 43(27). 2 indexed citations
9.
Valencia, Pedro M., Eric M. Pridgen, Suresh Gadde, et al.. (2012). Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles. Nanomedicine. 8(5). 687–698. 67 indexed citations
10.
Valencia, Pedro M., Omid C. Farokhzad, Rohit Karnik, & Róbert Langer. (2012). Microfluidic technologies for accelerating the clinical translation of nanoparticles. Nature Nanotechnology. 7(10). 623–629. 559 indexed citations breakdown →
11.
Valencia, Pedro M., et al.. (2011). Effects of ligands with different water solubilities on self-assembly and properties of targeted nanoparticles. Biomaterials. 32(26). 6226–6233. 152 indexed citations
12.
Rhee, Minsoung, et al.. (2011). Synthesis of Size‐Tunable Polymeric Nanoparticles Enabled by 3D Hydrodynamic Flow Focusing in Single‐Layer Microchannels. Advanced Materials. 23(12). H79–83. 186 indexed citations
14.
Kolishetti, Nagesh, Shanta Dhar, Pedro M. Valencia, et al.. (2010). Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proceedings of the National Academy of Sciences. 107(42). 17939–17944. 486 indexed citations
15.
Chan, Juliana M., Pedro M. Valencia, Liangfang Zhang, Róbert Langer, & Omid C. Farokhzad. (2010). Polymeric Nanoparticles for Drug Delivery. Methods in molecular biology. 624. 163–175. 247 indexed citations
16.
Valencia, Pedro M., Pamela A. Basto, Liangfang Zhang, et al.. (2010). Single-Step Assembly of Homogenous Lipid−Polymeric and Lipid−Quantum Dot Nanoparticles Enabled by Microfluidic Rapid Mixing. ACS Nano. 4(3). 1671–1679. 268 indexed citations
17.
Valencia, Pedro M., Minsoung Rhee, R. Langer, Omid C. Farokhzad, & Rohit Karnik. (2010). MERGING 'MICRO' WITH 'NANO': ON-CHIP HIGH-THROUGHPUT SYNTHESIS OF POLYMERIC NANOPARTICLES FOR CANCER THERAPY. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026